authors
- Tinker, A
- Hirte, Holger
- Provencher, D
- Butler, M
- Ritter, H
- Tu, D
- Paralejas, P
- Grenier, N
- Hahn, S
- Ramsahai, J
- Seymour, L
Dose ranging study of monalizumab (IPH2201) in patients with gynecologic malignancies: A trial of the Canadian Cancer Trials Group (CCTG): IND221
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 2016
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal